Nida Ziauddeen1,2, Deepti Gurdasani3, Margaret E O'Hara4, Claire Hastie4, Paul Roderick1, Guiqing Yao5, Nisreen A Alwan1,2,6. 1. School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. 2. NIHR Applied Research Collaboration Wessex, Southampton, United Kingdom. 3. William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. 4. Patient contributor, Long Covid Support: www.longcovid.org, London, United Kingdom. 5. Department of Health Science, University of Leicester, Leicester, United Kingdom. 6. NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Abstract
BACKGROUND: Long Covid is a public health concern that needs defining, quantifying, and describing. We aimed to explore the initial and ongoing symptoms of Long Covid following SARS-CoV-2 infection and describe its impact on daily life. METHODS: We collected self-reported data through an online survey using convenience non-probability sampling. The survey enrolled adults who reported lab-confirmed (PCR or antibody) or suspected COVID-19 who were not hospitalised in the first two weeks of illness. This analysis was restricted to those with self-reported Long Covid. Univariate comparisons between those with and without confirmed COVID-19 infection were carried out and agglomerative hierarchical clustering was used to identify specific symptom clusters, and their demographic and functional correlates. RESULTS: We analysed data from 2550 participants with a median duration of illness of 7.6 months (interquartile range (IQR) 7.1-7.9). 26.5% reported lab-confirmation of infection. The mean age was 46.5 years (standard deviation 11 years) with 82.8% females and 79.9% of participants based in the UK. 89.5% described their health as good, very good or excellent before COVID-19. The most common initial symptoms that persisted were exhaustion, chest pressure/tightness, shortness of breath and headache. Cognitive dysfunction and palpitations became more prevalent later in the illness. Most participants described fluctuating (57.7%) or relapsing symptoms (17.6%). Physical activity, stress, and sleep disturbance commonly triggered symptoms. A third (32%) reported they were unable to live alone without any assistance at six weeks from start of illness. 16.9% reported being unable to work solely due to COVID-19 illness. 37.0% reported loss of income due to illness, and 64.4% said they were unable to perform usual activities/duties. Acute systems clustered broadly into two groups: a majority cluster (n = 2235, 88%) with cardiopulmonary predominant symptoms, and a minority cluster (n = 305, 12%) with multisystem symptoms. Similarly, ongoing symptoms broadly clustered in two groups; a majority cluster (n = 2243, 88.8%) exhibiting mainly cardiopulmonary, cognitive symptoms and exhaustion, and a minority cluster (n = 283, 11.2%) exhibiting more multisystem symptoms. Belonging to the more severe multisystem cluster was associated with more severe functional impact, lower income, younger age, being female, worse baseline health, and inadequate rest in the first two weeks of the illness, with no major differences in the cluster patterns when restricting analysis to the lab-confirmed subgroup. CONCLUSION: This is an exploratory survey of Long Covid characteristics. Whilst this is a non-representative population sample, it highlights the heterogeneity of persistent symptoms, and the significant functional impact of prolonged illness following confirmed or suspected SARS-CoV-2 infection. To study prevalence, predictors and prognosis, research is needed in a representative population sample using standardised case definitions.
BACKGROUND: Long Covid is a public health concern that needs defining, quantifying, and describing. We aimed to explore the initial and ongoing symptoms of Long Covid following SARS-CoV-2 infection and describe its impact on daily life. METHODS: We collected self-reported data through an online survey using convenience non-probability sampling. The survey enrolled adults who reported lab-confirmed (PCR or antibody) or suspected COVID-19 who were not hospitalised in the first two weeks of illness. This analysis was restricted to those with self-reported Long Covid. Univariate comparisons between those with and without confirmed COVID-19 infection were carried out and agglomerative hierarchical clustering was used to identify specific symptom clusters, and their demographic and functional correlates. RESULTS: We analysed data from 2550 participants with a median duration of illness of 7.6 months (interquartile range (IQR) 7.1-7.9). 26.5% reported lab-confirmation of infection. The mean age was 46.5 years (standard deviation 11 years) with 82.8% females and 79.9% of participants based in the UK. 89.5% described their health as good, very good or excellent before COVID-19. The most common initial symptoms that persisted were exhaustion, chest pressure/tightness, shortness of breath and headache. Cognitive dysfunction and palpitations became more prevalent later in the illness. Most participants described fluctuating (57.7%) or relapsing symptoms (17.6%). Physical activity, stress, and sleep disturbance commonly triggered symptoms. A third (32%) reported they were unable to live alone without any assistance at six weeks from start of illness. 16.9% reported being unable to work solely due to COVID-19 illness. 37.0% reported loss of income due to illness, and 64.4% said they were unable to perform usual activities/duties. Acute systems clustered broadly into two groups: a majority cluster (n = 2235, 88%) with cardiopulmonary predominant symptoms, and a minority cluster (n = 305, 12%) with multisystem symptoms. Similarly, ongoing symptoms broadly clustered in two groups; a majority cluster (n = 2243, 88.8%) exhibiting mainly cardiopulmonary, cognitive symptoms and exhaustion, and a minority cluster (n = 283, 11.2%) exhibiting more multisystem symptoms. Belonging to the more severe multisystem cluster was associated with more severe functional impact, lower income, younger age, being female, worse baseline health, and inadequate rest in the first two weeks of the illness, with no major differences in the cluster patterns when restricting analysis to the lab-confirmed subgroup. CONCLUSION: This is an exploratory survey of Long Covid characteristics. Whilst this is a non-representative population sample, it highlights the heterogeneity of persistent symptoms, and the significant functional impact of prolonged illness following confirmed or suspected SARS-CoV-2 infection. To study prevalence, predictors and prognosis, research is needed in a representative population sample using standardised case definitions.
Authors: Hannah E Davis; Gina S Assaf; Lisa McCorkell; Hannah Wei; Ryan J Low; Yochai Re'em; Signe Redfield; Jared P Austin; Athena Akrami Journal: EClinicalMedicine Date: 2021-07-15
Authors: Alyson W Wong; Aditi S Shah; James C Johnston; Christopher Carlsten; Christopher J Ryerson Journal: Eur Respir J Date: 2020-11-26 Impact factor: 16.671
Authors: Andrea Dennis; Malgorzata Wamil; Johann Alberts; Jude Oben; Daniel J Cuthbertson; Dan Wootton; Michael Crooks; Mark Gabbay; Michael Brady; Lyth Hishmeh; Emily Attree; Melissa Heightman; Rajarshi Banerjee; Amitava Banerjee Journal: BMJ Open Date: 2021-03-30 Impact factor: 2.692
Authors: Tyler E Miller; Wilfredo F Garcia Beltran; Adam Z Bard; Tasos Gogakos; Melis N Anahtar; Michael Gerino Astudillo; Diane Yang; Julia Thierauf; Adam S Fisch; Grace K Mahowald; Megan J Fitzpatrick; Valentina Nardi; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Hetal D Marble; Lauren L Ritterhouse; Sara E Turbett; Julie Batten; Nicholas Zeke Georgantas; Galit Alter; Aaron G Schmidt; Jason B Harris; Jeffrey A Gelfand; Mark C Poznansky; Bradley E Bernstein; David N Louis; Anand Dighe; Richelle C Charles; Edward T Ryan; John A Branda; Virginia M Pierce; Mandakolathur R Murali; A John Iafrate; Eric S Rosenberg; Jochen K Lennerz Journal: FASEB J Date: 2020-08-28 Impact factor: 5.834
Authors: Justin Reese; Hannah Blau; Timothy Bergquist; Johanna J Loomba; Tiffany Callahan; Bryan Laraway; Corneliu Antonescu; Elena Casiraghi; Ben Coleman; Michael Gargano; Kenneth Wilkins; Luca Cappelletti; Tommaso Fontana; Nariman Ammar; Blessy Antony; T M Murali; Guy Karlebach; Julie A McMurry; Andrew Williams; Richard Moffitt; Jineta Banerjee; Anthony E Solomonides; Hannah Davis; Kristin Kostka; Giorgio Valentini; David Sahner; Christopher G Chute; Charisse Madlock-Brown; Melissa A Haendel; Peter N Robinson Journal: medRxiv Date: 2022-05-25
Authors: Kelly K O'Brien; Darren A Brown; Colm Bergin; Kristine M Erlandson; Jaime H Vera; Lisa Avery; Soo Chan Carusone; Angela M Cheung; Susie Goulding; Richard Harding; Lisa McCorkell; Margaret O'Hara; Larry Robinson; Catherine Thomson; Hannah Wei; Natalie St Clair-Sullivan; Brittany Torres; Ciaran Bannan; Niamh Roche; Ruth Stokes; Patriic Gayle; Patricia Solomon Journal: BMJ Open Date: 2022-03-07 Impact factor: 2.692